Skip to main content
. 2022 Oct 6;69(3):3–8. doi: 10.2344/anpr-69-01-05

Table 1.

Univariate Analysis: Postoperative Sore Throat Risk Factors*


Sore throat group (n = 126)
Nonsore throat group (n = 43)
P value
DL
McGRATH
Pentax-AWS
FIO
DL
McGRATH
Pentax-AWS
FIO
Airway device 41 28 23 34 9 15 15 4 <.05†
Sex, m/f 20/21 17/11 12/11 23/11 6/3 7/8 10/5 1/3 1†
Age, y 38.8 ± 17.7 44.1 ± 18.4 37.7 ± 18.4 52.9 ± 18.9 66.2 ± 12.2 51.5 ± 21.5 44.1 ± 20.1 25.3 ± 7.4 .12‡
Height, cm 161.9 ± 9.0 166.6 ± 8.0 164.8 ± 8.5 163.6 ± 6.2 163.7 ± 9.7 159.0 ± 13.4 165.2 ± 6.6 161.2 ± 8.2 .39‡
Weight, kg 59.3 ± 14.0 60.0 ± 11.1 62.1 ± 13.2 59.1 ± 11.8 63.1 ± 13.4 54.5 ± 10.0 63.1 ± 8.6 56.0 ± 7.4 .82‡
ASA classification, 1/2/3 32/9/0 17/11/10 15/8/0 11/22/1 0/9/0 7/8/0 9/6/0 2/2/0 .06§
Intubation attempt, 1st, 2nd, 3rd 29/6/6 27/0/1 21/1/1 27/6/1 9/0/0 12/2/1 15/0/0 4/0/0 .04‡
Duration of intubation, min 209.7 ± 92.0 241.0 ± 125.8 201.9 ± 65.0 246.9 ± 143.9 243.1 ± 68.6 213.2 ± 105. 210.5 ± 95.3 211.0 ± 42.9 .69‡
Intubation time, s 95.8 ± 86.1 81.4 ± 64.8 82.3 ± 75.9 102.9 ± 54.2 59.6 ± 24.2 91.9 ±80.4 69.9 ± 33.7 134.0 ± 65.9 .35‡
Tube size, 6/6.5/7/7.5/8 1/12/12/16/0 0/4/9/15/0 0/4/8/11/0 0/6/8/20/0 0/0/4/5/0 0/5/4/5/1 0/4/1/10/0 0/2/1/1/0 .99‡
Fentanyl, μg 326.8 ± 141.9 391.1 ± 169.1 350.0 ± 87.2 333.8 ± 161.7 377.8 ± 122.7 293.3 ± 293.3 360.0 ± 102.0 375.0 ± 109.0 .82‡
Remifentanil, μg 2296.5 ± 2025.6 2806.6 ± 1932.7 2706.2 ± 1730.5 2402.8 ± 2096.3 1684.5 ± 1063.9 1730.6 ± 1474.8 2432.6 ± 1294.1 2208.1 ± 753.9 .07‡
* 

Quantitative or qualitative data were shown in means ± SD or number of occurrences, respectively. ASA, American Society of Anesthesiologists; DL, direct laryngoscopy with Macintosh blade; FIO, fiberoptic scope.

† 

Fisher exact test used to compare the groups for univariate analysis.

‡ 

Welch t test used to compare the groups for univariate analysis.

§ 

Wilcoxon rank sum test used to compare the groups for univariate analysis.